Growth in High-Performance Construction Chapman Construction/Design's recent project awards for high-performance buildings, including the new headquarters for Akebia Therapeutics, position the company as a key player in the life sciences and healthcare sectors. This focus presents opportunities to offer specialized construction solutions tailored to biotech and medical clients seeking sustainable and innovative facilities.

Expansion into International Markets The company's recent expansion into Manchester, United Kingdom, indicates a strategic move to grow its footprint in Europe. Sales efforts could target multinational corporations and organizations planning cross-border projects, emphasizing Chapman's global capabilities and local expertise.

Focus on Sustainability and Teamwork Chapman emphasizes teamwork, excellence, and sustainability in its approach, making it an attractive partner for clients with ESG priorities. Leveraging this positioning, sales teams can target companies seeking construction partners aligned with their sustainability goals and collaborative project delivery models.

Client Portfolio in Life Sciences With recent projects for life sciences clients like Akebia Therapeutics and a focus on constructing advanced research facilities, there is a clear opportunity to pursue additional biotech, pharmaceutical, and healthcare organizations seeking expert construction management for complex, high-tech facilities.

Mid-Sized Market Focus Operating within the $50M to $100M revenue range and maintaining a team of up to 200 employees, Chapman is well-positioned to engage mid-market clients looking for personalized service and flexibility. Sales efforts can emphasize Chapman's bespoke approach and extensive experience in managing large-scale, sophisticated projects.